Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

215 Press Releases
DateTitleCompany
14 Oct 16 Amgen Announces Appointment Of Ellen J. Kullman To Board Of Directors Amgen,
Published by
PR Newswire
14 Oct 16 Amgen Announces 2016 Fourth Quarter Dividend Amgen,
Published by
PR Newswire
04 Oct 16 Amgen To Participate In Citi Biotech R&D Conference Call Amgen,
Published by
PR Newswire
30 Sep 16 Amgen Announces Erenumab Significantly Reduces Monthly Migraine Days In Patients With Episodic Migraine In First Phase 3 Study Amgen ,
Published by
PharmiWeb.com
26 Sep 16 Amgen And UCB Announce U.S. FDA Acceptance Of Biologics License Application For Romosozumab Amgen,
Published by
PR Newswire
14 Sep 16 Amgen To Webcast Investor Call Amgen,
Published by
PR Newswire
13 Sep 16 Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference Amgen,
Published by
PR Newswire
01 Sep 16 FDA Approves BLINCYTO® (blinatumomab) For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-cell Precursor Acute Lymphoblastic Leukemia Amgen,
Published by
PR Newswire
29 Aug 16 Amgen Announces Positive Top-Line Results From Phase 3 Study Of Prolia® (Denosumab) In Patients Receiving Glucocorticoid Therapy Amgen ,
Published by
PharmiWeb.com
24 Aug 16 Amgen Provides Update On Status Of Parsabiv™ (Etelcalcetide) New Drug Application (NDA) Submitted To The U.S. Food And Drug Administration (FDA) Amgen,
Published by
PR Newswire
02 Aug 16 Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration Amgen,
Published by
PR Newswire
22 Jul 16 Amgen Announces 2016 Third Quarter Dividend Amgen,
Published by
PR Newswire
22 Jun 16 Amgen Sponsors QB3@953 Incubator For Life Science Startups Amgen,
Published by
PR Newswire
17 Jun 16 Amgen Appoints Esteban Santos Executive Vice President, Operations Amgen,
Published by
PR Newswire
13 Jun 16 Amgen Announces FDA Advisory Committee Meeting To Review ABP 501, A Biosimilar Candidate To Adalimumab Amgen,
Published by
PR Newswire
10 Jun 16 Amgen Announces Erenumab (AMG 334) Significantly Reduces Patients' Monthly Migraine Days In Phase 2 Study For The Prevention Of Chronic Migraine Amgen,
Published by
PharmiWeb.com
03 Jun 16 Amgen To Present At The Goldman Sachs 37th Annual Global Healthcare Conference Amgen,
Published by
PR Newswire
17 May 16 Amgen's Breakaway from Cancer® Public Service Announcement Delivers Message That Education, Resources And Hope Are Essential In The Fight Against Cancer Amgen,
Published by
PR Newswire
10 Feb 16 Amgen To Present At The Leerink Partners 5th Annual Global Healthcare Conference Amgen ,
Published by
PharmiWeb.com
12 Feb 16 New Drug Treatment Kyprolis® ? (carfilzomib) for Relapsed Multiple Myeloma Launches in the UK Amgen,
Published by
PR Newswire
06 May 16 Amgen To Present At The Bank Of America Merrill Lynch 2016 Health Care Conference Amgen,
Published by
PR Newswire
07 Mar 16 Amgen Announces 2016 Second Quarter Dividend Amgen ,
Published by
PharmiWeb.com
06 Apr 16 Saxenda® (liraglutide [rDNA origin] injection) Demonstrated Significant Improvements in Cardiometabolic Risk Factors Over Three Years Compared With Placebo Amgen,
Published by
PharmiWeb.com
06 Apr 16 Positive Efficacy And Tolerability Study Of Repatha® (evolocumab) In Statin-Intolerant Patients Published In Journal of the American Medical Association Amgen,
Published by
PharmiWeb.com
09 May 16 NICE Sets Out Draft Recommendations For Repatha® (Evolocumab) In Final Appraisal Determination Amgen
28 Apr 16 Amgen To Participate In The 2016 World Medical Innovation Forumâ„¢ On Cancer Amgen ,
Published by
PharmiWeb.com
27 Jan 16 FDA Accepts Amgen's Biosimilar Biologics License Application For ABP 501 Amgen,
Published by
PharmiWeb.com
27 Jan 16 Amgen Announces Webcast of 2015 Fourth Quarter and Full Year Financial Results Amgen,
Published by
PharmiWeb.com
27 Jan 16 Vectibix® (panitumumab) And Best Supportive Care Improves Overall Survival Compared To Best Supportive Care In Chemorefractory KRAS And RAS Wild-Type Metastatic Colorectal Cancer Amgen,
Published by
PharmiWeb.com
16 Mar 16 Amgen Wins Patent Case On Repatha® (Evolocumab) Amgen,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.